Peter Hunt

1.4k total citations
42 papers, 1.0k citations indexed

About

Peter Hunt is a scholar working on Molecular Biology, Computational Theory and Mathematics and Spectroscopy. According to data from OpenAlex, Peter Hunt has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Computational Theory and Mathematics and 11 papers in Spectroscopy. Recurrent topics in Peter Hunt's work include Computational Drug Discovery Methods (16 papers), Analytical Chemistry and Chromatography (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Peter Hunt is often cited by papers focused on Computational Drug Discovery Methods (16 papers), Analytical Chemistry and Chromatography (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Peter Hunt collaborates with scholars based in United Kingdom, United States and Switzerland. Peter Hunt's co-authors include Matthew Segall, José L. Castro, Mark S. Shearman, Dirk Beher, Alan Nadin, Earl E. Clarke, Graeme I. Stevenson, Adrian L. Smith, Huw D. Lewis and Tim J. Harrison and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Peter Hunt

41 papers receiving 983 citations

Peers

Countries citing papers authored by Peter Hunt

Since Specialization

Citations

This map shows the geographic impact of Peter Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hunt more than expected).

Fields of papers citing papers by Peter Hunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hunt. The network helps show where Peter Hunt may publish in the future.

Co-authorship network of co-authors of Peter Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hunt. A scholar is included among the top collaborators of Peter Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hunt. Peter Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting Regioselectivity of AO, CYP, FMO, and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning 2022 ·Journal of Medicinal Chemistry ·Mario Öeren, Peter Walton, (unknown), David J. Ponting, Peter Hunt, Matthew Segall	15
2	Predicting reactivity to drug metabolism: beyond P450s—modelling FMOs and UGTs 2020 ·Journal of Computer-Aided Molecular Design ·Mario Öeren, Peter Walton, Peter Hunt, David J. Ponting, Matthew Segall	15
3	Capturing and applying knowledge to guide compound optimisation 2019 ·Drug Discovery Today ·Matthew Segall, (unknown), Peter Hunt, (unknown)	4
4	High-Quality Hits from High-Throughput Screens 2018 ·Genetic Engineering & Biotechnology News ·(unknown), Peter Hunt, (unknown), Matthew Segall	2
5	WhichP450: a multi-class categorical model to predict the major metabolising CYP450 isoform for a compound 2018 ·Journal of Computer-Aided Molecular Design ·Peter Hunt, Matthew Segall, Jonathan D. Tyzack	56
6	Breaking free from chemical spreadsheets 2015 ·Drug Discovery Today ·Matthew Segall, (unknown), (unknown), James A. Chisholm, Peter Hunt, Alex Elliott, Héctor García García, (unknown), (unknown)	4
7	GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014 2015 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Alexander Heifetz, Gebhard F. X. Schertler, Roland Seifert, Christopher G. Tate, Patrick M. Sexton, Vsevolod V. Gurevich, Daniel Fourmy, Vadim Cherezov, Fiona H. Marshall, Richard Storer, Isabel Moraes, Irina G. Tikhonova, Christofer S. Tautermann, Peter Hunt, Tom Ceska, Simon T. Hodgson, Mike J. Bodkin, Shweta Singh, Richard Law, Philip C. Biggin	28
8	The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Zarin Brown, Steven J. Charlton, Brian J. Cox, Peter Hunt, (unknown), Sarah Lewis, Paul Oakley, (unknown), John Reilly, (unknown), Neil J. Press	15
9	The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists 2013 ·Bioorganic & Medicinal Chemistry Letters ·David W. Porter, (unknown), Zarin Brown, (unknown), Steven J. Charlton, Brian J. Cox, Peter Hunt, (unknown), Sarah Lewis, (unknown), John Reilly, Carsten Spanka, Lauren Tedaldi, Simon J. Watson, (unknown), Neil J. Press	17
10	Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: Quaternary amines 2011 ·Bioorganic & Medicinal Chemistry Letters ·Thomas A. Hunt, (unknown), (unknown), Stephen P. Collingwood, K. Coote, Brian J. Cox, (unknown), Henry Danahay, (unknown), (unknown), Peter Hunt, (unknown), (unknown), Alice C. Young	23
11	Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors 2005 ·Archives of Biochemistry and Biophysics ·Michael Fricker, Philip V. LoGrasso, (unknown), Neil Wilkie, Peter Hunt, Scott J. Pollack	11
12	Molecular Transformations as a Way of Finding and Exploiting Consistent Local QSAR 2005 ·Journal of Chemical Information and Modeling ·Robert P. Sheridan, Peter Hunt, J. Chris Culberson	64
13	Multiple structural features of steroids mediate subtype-selective effects on human α4β3δ GABAA receptors 2004 ·Biochemical Pharmacology ·Gopalan V. Pillai, Alison J. Smith, Peter Hunt, Peter B. Simpson	12
14	Conserved residues within the putative active site of γ‐secretase differentially influence enzyme activity and inhibitor binding 2004 ·Journal of Neurochemistry ·Jonathan D.J. Wrigley, (unknown), Omar Nyabi, Earl E. Clarke, Peter Hunt, Alan Nadin, Bart De Strooper, Mark S. Shearman, Dirk Beher	18
15	Iodocyclisation of N-allyl ureas; a route to imidazolin-2-ones 2000 ·ARKIVOC ·Christopher J. Moody, Peter Hunt, Carl Smith	4
16	Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1 and 5-HT re-uptake ligands 1999 ·Bioorganic & Medicinal Chemistry Letters ·Monique B. van Niel, Margaret S. Beer, (unknown), (unknown), David C. Evans, Anne Heald, Laure Hitzel, Peter Hunt, Russell J. Mortishire‐Smith, Desmond O’Connor, Alan P. Watt, Angus M. MacLeod	10
17	QSAR using 2D descriptors and TRIPOS' SIMCA 1999 ·Journal of Computer-Aided Molecular Design ·Peter Hunt	9
18	Beckmann rearrangements in bicyclo[2.2.1]heptan-2-one oximes 1992 ·Journal of the Chemical Society Perkin Transactions 1 ·Peter Hunt, Christopher J. Moody, Alexandra M. Z. Slawin, David J. Williams, Peter L. Myers, Carl Smith	2
19	Angiotensin-Converting Enzyme in Rat Brain and Extraneural Tissues Visualized by Quantitative Autoradiography Using 3H-Trandolaprilate 1989 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), Manuel Worcel, Peter Hunt	15
20	Interactions of water soluble porphyrins with Z-poly(dG-dC) 1986 ·Nucleic Acids Research ·Robert F. Pasternack, (unknown), Peter Hunt, (unknown), Julian H. Gibbs	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact